FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134780225> ?p ?o ?g. }

• W2134780225 abstract "Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 1 in 68 children in the United States. Even though it is a common disorder, only two medications (risperidone and aripiprazole) are approved by the U.S. Food and Drug Administration (FDA) to treat symptoms associated with ASD. However, these medications are approved to treat irritability, which is not a core symptom of ASD. A number of novel medications, which have not been approved by the FDA to treat ASD have been used off-label in some studies to treat ASD symptoms, including medications approved for Alzheimer's disease. Interestingly, some of these studies are high-quality, double-blind, placebo-controlled (DBPC) studies. This article systematically reviews studies published through April, 2014, which examined the use of Alzheimer's medications in ASD, including donepezil (seven studies, two were DBPC, five out of seven reported improvements), galantamine (four studies, two were DBPC, all reported improvements), rivastigmine (one study reporting improvements), tacrine (one study reporting improvements), and memantine (nine studies, one was DBPC, eight reported improvements). An evidence-based scale was used to rank each medication. Collectively, these studies reported improvements in expressive language and communication, receptive language, social interaction, irritability, hyperactivity, attention, eye contact, emotional lability, repetitive or self-stimulatory behaviors, motor planning, disruptive behaviors, obsessive-compulsive symptoms, lethargy, overall ASD behaviors, and increased REM sleep. Reported side effects are reviewed and include irritability, gastrointestinal problems, verbal or behavioral regression, headaches, irritability, rash, tremor, sedation, vomiting, and speech problems. Both galantamine and memantine had sufficient evidence ranking for improving both core and associated symptoms of ASD. Given the lack of medications approved to treat ASD, further studies on novel medications, including Alzheimer's disease medications, are needed." @default.
• W2134780225 created "2016-06-24" @default.
• W2134780225 creator A5021143842 @default.
• W2134780225 creator A5062709739 @default.
• W2134780225 date "2014-08-22" @default.
• W2134780225 modified "2023-10-01" @default.
• W2134780225 title "The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review" @default.
• W2134780225 cites W1488489801 @default.
• W2134780225 cites W1520936573 @default.
• W2134780225 cites W1964444099 @default.
• W2134780225 cites W1967183236 @default.
• W2134780225 cites W1969516074 @default.
• W2134780225 cites W1970096763 @default.
• W2134780225 cites W1974307776 @default.
• W2134780225 cites W1981622026 @default.
• W2134780225 cites W1985355141 @default.
• W2134780225 cites W1988195121 @default.
• W2134780225 cites W1989532443 @default.
• W2134780225 cites W1994168324 @default.
• W2134780225 cites W2000484318 @default.
• W2134780225 cites W2003821733 @default.
• W2134780225 cites W2015191889 @default.
• W2134780225 cites W2015606490 @default.
• W2134780225 cites W2022138812 @default.
• W2134780225 cites W2024948778 @default.
• W2134780225 cites W2029858747 @default.
• W2134780225 cites W2034220807 @default.
• W2134780225 cites W2042211936 @default.
• W2134780225 cites W2050507992 @default.
• W2134780225 cites W2056828397 @default.
• W2134780225 cites W2057972330 @default.
• W2134780225 cites W2072983646 @default.
• W2134780225 cites W2082404293 @default.
• W2134780225 cites W2083630218 @default.
• W2134780225 cites W2085662710 @default.
• W2134780225 cites W2103535314 @default.
• W2134780225 cites W2104165977 @default.
• W2134780225 cites W2105523866 @default.
• W2134780225 cites W2110117116 @default.
• W2134780225 cites W2111485803 @default.
• W2134780225 cites W2116497718 @default.
• W2134780225 cites W2119098759 @default.
• W2134780225 cites W2122550040 @default.
• W2134780225 cites W2125870174 @default.
• W2134780225 cites W2131568512 @default.
• W2134780225 cites W2144632316 @default.
• W2134780225 cites W2144994270 @default.
• W2134780225 cites W2147058453 @default.
• W2134780225 cites W2148367140 @default.
• W2134780225 cites W2154767575 @default.
• W2134780225 cites W2156615834 @default.
• W2134780225 cites W2159733258 @default.
• W2134780225 cites W2169588646 @default.
• W2134780225 cites W4321429169 @default.
• W2134780225 doi "https://doi.org/10.3389/fped.2014.00087" @default.
• W2134780225 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4141213" @default.
• W2134780225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25202686" @default.
• W2134780225 hasPublicationYear "2014" @default.
• W2134780225 type Work @default.
• W2134780225 sameAs 2134780225 @default.
• W2134780225 citedByCount "59" @default.
• W2134780225 countsByYear W21347802252014 @default.
• W2134780225 countsByYear W21347802252015 @default.
• W2134780225 countsByYear W21347802252016 @default.
• W2134780225 countsByYear W21347802252017 @default.
• W2134780225 countsByYear W21347802252018 @default.
• W2134780225 countsByYear W21347802252019 @default.
• W2134780225 countsByYear W21347802252020 @default.
• W2134780225 countsByYear W21347802252021 @default.
• W2134780225 countsByYear W21347802252022 @default.
• W2134780225 countsByYear W21347802252023 @default.
• W2134780225 crossrefType "journal-article" @default.
• W2134780225 hasAuthorship W2134780225A5021143842 @default.
• W2134780225 hasAuthorship W2134780225A5062709739 @default.
• W2134780225 hasBestOaLocation W21347802251 @default.
• W2134780225 hasConcept C118552586 @default.
• W2134780225 hasConcept C126322002 @default.
• W2134780225 hasConcept C187212893 @default.
• W2134780225 hasConcept C205778803 @default.
• W2134780225 hasConcept C2776332859 @default.
• W2134780225 hasConcept C2776412080 @default.
• W2134780225 hasConcept C2776703358 @default.
• W2134780225 hasConcept C2778538070 @default.
• W2134780225 hasConcept C2779056891 @default.
• W2134780225 hasConcept C2779134260 @default.
• W2134780225 hasConcept C2779483572 @default.
• W2134780225 hasConcept C2779484449 @default.
• W2134780225 hasConcept C2780057945 @default.
• W2134780225 hasConcept C2780211496 @default.
• W2134780225 hasConcept C2780634440 @default.
• W2134780225 hasConcept C2780820931 @default.
• W2134780225 hasConcept C2780904820 @default.
• W2134780225 hasConcept C558461103 @default.
• W2134780225 hasConcept C70410870 @default.
• W2134780225 hasConcept C71924100 @default.
• W2134780225 hasConceptScore W2134780225C118552586 @default.
• W2134780225 hasConceptScore W2134780225C126322002 @default.
• W2134780225 hasConceptScore W2134780225C187212893 @default.
• W2134780225 hasConceptScore W2134780225C205778803 @default.
• W2134780225 hasConceptScore W2134780225C2776332859 @default.

• next